Acorah Software Products - Accounts Production 16.0.110 false true 31 October 2022 1 November 2021 false 1 November 2022 31 October 2023 31 October 2023 04920144 Dr Edmond Edi-Osagie Dr Edmond Edi-Osagie true iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 04920144 2022-10-31 04920144 2023-10-31 04920144 2022-11-01 2023-10-31 04920144 frs-core:Non-currentFinancialInstruments 2023-10-31 04920144 frs-core:ComputerEquipment 2022-11-01 2023-10-31 04920144 frs-core:PlantMachinery 2022-11-01 2023-10-31 04920144 frs-core:ShareCapital 2023-10-31 04920144 frs-core:RetainedEarningsAccumulatedLosses 2023-10-31 04920144 frs-bus:PrivateLimitedCompanyLtd 2022-11-01 2023-10-31 04920144 frs-bus:AbridgedAccounts 2022-11-01 2023-10-31 04920144 frs-bus:SmallEntities 2022-11-01 2023-10-31 04920144 frs-bus:AuditExempt-NoAccountantsReport 2022-11-01 2023-10-31 04920144 frs-bus:SmallCompaniesRegimeForAccounts 2022-11-01 2023-10-31 04920144 frs-bus:OrdinaryShareClass2 2022-11-01 2023-10-31 04920144 frs-bus:OrdinaryShareClass2 2023-10-31 04920144 frs-bus:OrdinaryShareClass3 2022-11-01 2023-10-31 04920144 frs-bus:OrdinaryShareClass3 2023-10-31 04920144 1 2022-11-01 2023-10-31 04920144 frs-bus:Director1 2022-11-01 2023-10-31 04920144 frs-bus:Director1 2022-10-31 04920144 frs-bus:Director1 2023-10-31 04920144 frs-bus:CompanySecretary1 2022-11-01 2023-10-31 04920144 frs-countries:EnglandWales 2022-11-01 2023-10-31 04920144 2021-10-31 04920144 2022-10-31 04920144 2021-11-01 2022-10-31 04920144 frs-core:Non-currentFinancialInstruments 2022-10-31 04920144 frs-core:ShareCapital 2022-10-31 04920144 frs-core:RetainedEarningsAccumulatedLosses 2022-10-31 04920144 frs-bus:OrdinaryShareClass2 2021-11-01 2022-10-31 04920144 frs-bus:OrdinaryShareClass3 2021-11-01 2022-10-31
Registered number: 04920144
OMONDI HEALTHCARE LIMITED
ABRIDGED Financial Statements
For The Year Ended 31 October 2023
John A. Porter & Co.
74 Dickenson Road
Rusholme
Manchester
M14 5HF
Contents
Page
Abridged Balance Sheet 1—2
Notes to the Abridged Financial Statements 3—5
Page 1
Abridged Balance Sheet
Registered number: 04920144
2023 2022
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 40,027 49,158
40,027 49,158
CURRENT ASSETS
Stocks 5 9,565 12,880
Debtors 275,136 261,760
Investments 35,000 35,000
Cash at bank and in hand 22,456 65,899
342,157 375,539
Creditors: Amounts Falling Due Within One Year (307,812 ) (358,753 )
NET CURRENT ASSETS (LIABILITIES) 34,345 16,786
TOTAL ASSETS LESS CURRENT LIABILITIES 74,372 65,944
Creditors: Amounts Falling Due After More Than One Year (27,574 ) (55,247 )
NET ASSETS 46,798 10,697
CAPITAL AND RESERVES
Called up share capital 7 100 100
Profit and Loss Account 46,698 10,597
SHAREHOLDERS' FUNDS 46,798 10,697
Page 1
Page 2
For the year ending 31 October 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
All of the company's members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet for the year end 31 October 2023 in accordance with section 444(2A) of the Companies Act 2006.
The financial statements were approved by the board of directors on 28 October 2024 and were signed on its behalf by:
Dr Edmond Edi-Osagie
Director
28 October 2024
The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Notes to the Abridged Financial Statements
1. General Information
OMONDI HEALTHCARE LIMITED is a private company, limited by shares, incorporated in England & Wales.
The registered number is 04920144 .
The registered office is 74 Dickenson Road, Rusholme, Manchester, M14 5HF.
Dividends paid to the Directors are reported in the notes to the accounts.
Related party transactions are reported in the notes to the accounts.
Post balance sheet events are reported in the notes to the accounts.
There are no other related party transactions to report.
There are no contingent liabilities or other post balance sheet events to report.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover represents total invoiced fees for health care services. The business is not Value Added Tax (VAT) registered.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are stated at cost less accumulated depreciation.
Depreciation is calculated at the following annual rates in order to write off each asset over its estimated useful life. 
Plant & Machinery 20% Reducing Balance
Computer Equipment 20% Reducing Balance
No depreciation is charged in the year of acquisition.
2.4. Stocks and Work in Progress
Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.
Work in Progress is valued at the prime cost of labour and materials plus other direct expenses.
2.5. Pensions
The company operates a defined pension contribution scheme. Contributions are charged to the profit and loss account as they become payable in accordance with the rules of the scheme.
2.6. Accounting Reference Date
The accounting reference date is 27 October.
These accounts are nevertheless for the year ended 31 October 2023.
2.7. Comparative Figures
The comparative figures used throughout these accounts are as at 31 October 2022 or are for the year ended on that date.
2.8. Registrar Filing Requirements
The company has taken advantage of Companies Act 2006 section 444(1) and opted not to file the profit and loss account, directors report, and notes to the financial statements relating to the profit and loss account.
3. Average Number of Employees
Average number of employees, including directors, who are employed under a contract of service during the year was as follows:
2023 2022
Office and administration 3 3
3 3
Page 3
Page 4
4. Tangible Assets
Total
£
Cost
As at 1 November 2022 79,545
Additions 400
As at 31 October 2023 79,945
Depreciation
As at 1 November 2022 30,387
Provided during the period 9,531
As at 31 October 2023 39,918
Net Book Value
As at 31 October 2023 40,027
As at 1 November 2022 49,158
5. Stocks
2023 2022
£ £
Work in progress 9,565 12,880
6. Secured Creditors
Of the creditors the following amounts are secured.
2023 2022
£ £
Bank loans and overdrafts 34,198 88,158
7. Share Capital
2023 2022
Allotted, called up and fully paid £ £
50 Ordinary A shares of £ 1.00 each 50 50
50 Ordinary B shares of £ 1.00 each 50 50
100 100
8. Pension Commitments
The company operates a defined contribution pension scheme.
The assets of the scheme are held separately from those of the company in an independently administered fund. At the balance sheet date contributions of £362 (2022 £308) were due to the fund and are included in Other Creditors.
Page 4
Page 5
9. Directors Advances, Credits and Guarantees
Included within Debtors are the following loans to directors:
As at 1 November 2022 Amounts advanced Amounts repaid Amounts written off As at 31 October 2023
£ £ £ £ £
Dr Edmond Edi-Osagie 225,896 71,989 (72,000 ) - 225,885
The overdrawn loan account is unsecured and repayable on demand.
The loan was subject to interest calculated by reference to the official rate of interest which was 2.00% rising to 2.25% in April 2023.
The amount of interest charged totalled £5,090 (2022 £4,217) and is included in amounts advanced.
The maximum overdrawn balance during the year was £255,024 (2022 £275,629).
Dividends paid to directors
2023 2022
£ £
Dr Edmond Edi-Osagie - 18,500
10. Related Party Transactions
Associated Companies
ProFertil (UK) Limited is an associated company under the control of the two directors. Dr Edmond Edi-Osagie holds 520 £1 Ordinary Shares representing 72.22% of the issued share capital and Dr Ngozi Edi-Osagie owns 200 £1 Ordinary Shares representing 27.78% of the issued capital, there being a total of 720 £1 Ordinary Shares in issue.
Dr Edmond Edi-Osagie & Dr Ngozi Edi-Osagie are both directors of ProFertil (UK) Limited.
Charges totalling £51,560 (2022 £86,770) were made in the year by ProFertil (UK) Limited for surgical support and assistance and are included in direct costs. The directors report that charges are set in accordance with open market rates.
11. Ultimate Controlling Party
The Company was controlled throughout the year by Dr Edmond Edi-Osagie & Dr Ngozi Edi-Osagie who each hold 50 £1 ordinary voting shares, there being 100 £1 ordinary voting shares in issue.
Page 5